No abstract available
Keywords:
CD40L (CD154); cancer microenvironment; chronic lymphocytic leukemia; small molecular pathway inhibitors.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antigens, CD19 / genetics
-
Antigens, CD19 / immunology
-
Antineoplastic Agents / pharmacology*
-
B-Lymphocytes / drug effects*
-
B-Lymphocytes / immunology
-
B-Lymphocytes / pathology
-
CD40 Ligand / antagonists & inhibitors*
-
CD40 Ligand / genetics
-
CD40 Ligand / immunology
-
CD40 Ligand / pharmacology
-
Cell Proliferation / drug effects
-
Clinical Trials as Topic
-
Cyclohexylamines / pharmacology
-
Gene Expression Regulation, Leukemic*
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
-
Leukemia, Lymphocytic, Chronic, B-Cell / genetics
-
Leukemia, Lymphocytic, Chronic, B-Cell / immunology
-
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
-
Lymphocyte Activation
-
Organ Specificity
-
Oxazines / pharmacology
-
Primary Cell Culture
-
Protein Kinase Inhibitors / pharmacology*
-
Pyridines / pharmacology
-
Pyrimidines / pharmacology
-
Signal Transduction
-
Spleen / drug effects
-
Spleen / immunology
-
Spleen / pathology
-
Syk Kinase / antagonists & inhibitors*
-
Syk Kinase / genetics
-
Syk Kinase / immunology
-
Transcription Factor RelA / genetics
-
Transcription Factor RelA / immunology
-
p38 Mitogen-Activated Protein Kinases / genetics
-
p38 Mitogen-Activated Protein Kinases / immunology
Substances
-
4-(3-(2H-1,2,3-triazol-2-yl)phenylamino)-2-(2-aminocyclohexylamino)pyrimidine-5-carboxamide
-
Antigens, CD19
-
Antineoplastic Agents
-
CD19 molecule, human
-
Cyclohexylamines
-
N4-(2,2-dimethyl-3-oxo-4H-pyrid(1,4)oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine
-
Oxazines
-
Protein Kinase Inhibitors
-
Pyridines
-
Pyrimidines
-
Transcription Factor RelA
-
CD40 Ligand
-
SYK protein, human
-
Syk Kinase
-
p38 Mitogen-Activated Protein Kinases